Peptide-MHC Class I Tetrameric Complexes Display Exquisite Ligand Specificity
Open Access
- 1 December 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 165 (11) , 6229-6234
- https://doi.org/10.4049/jimmunol.165.11.6229
Abstract
The production of synthetic MHC-peptide tetramers has revolutionized cellular immunology by revealing enormous CD8+ T cell expansions specific for peptides from various pathogens. A feature of these reagents, essential for their staining function, is that they bind T cells with relatively high avidity. This could, theoretically, promote cross-reactivity with irrelevant T cells leading to overestimates of epitope-specific T cell numbers. Therefore, we have investigated the fine specificity of CTL staining with these reagents for comparison with functional data. Using a panel of CTL clones with distinct fine specificity patterns for analogs of an HLA-B8-binding EBV epitope, together with B8 tetramers incorporating these peptides, we show a very good correlation between tetramer staining and peptide activity in cytotoxicity assays. Significant staining only occurred with tetramers that incorporate strong stimulatory agonist peptides and not weak agonists that are unlikely to induce full T cell activation at physiological levels of presentation. In almost every case where a peptide analog had >10-fold less activity than the optimal EBV peptide in cytotoxicity assays, the corresponding tetramer stained with >10-fold less intensity than the EBV epitope tetramer. Furthermore, by examining an EBV-specific clonotypic T cell expansion in EBV-exposed individuals, we show similar fine specificity in tetramer staining of fresh peripheral T cells. Collectively, our data demonstrate the exquisite specificity of class I MHC-peptide tetramers, underlining their accuracy in quantifying only those T cells capable of recognizing the low levels of cell surface peptide presented after endogenous Ag processing.Keywords
This publication has 28 references indexed in Scilit:
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivityEuropean Journal of Immunology, 1997
- Human leukocyte antigen phenotype imposes complex constraints on the antigen‐specific cytotoxic T lymphocyte repertoireEuropean Journal of Immunology, 1997
- Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell BiologyAnnual Review of Immunology, 1996
- Production and crystallization of MHC class I B allele single peptide complexesFEBS Letters, 1996
- Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.The Journal of Experimental Medicine, 1995
- Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27European Journal of Immunology, 1994
- Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virusEuropean Journal of Immunology, 1992
- The Minimal Number of Class II MHC-Antigen Complexes Needed for T Cell ActivationScience, 1990
- Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsNature, 1988